摘要
目的:近年来,不同类型的微卫星不稳定性(MSI)指定的不稳定性升高在选定的四核苷酸重复微卫星改变”(EMAST)已在一些肿瘤的报道,但其临床意义尚不清楚。我们的目的是确定在EMAST关系,MSI和临床病理特征,包括肿瘤结果,结直肠癌(CRC)。 材料与方法:我们评估了100例散发性CRC进行手术,使用五个标记(把mycl1,d9s242,D20S85,d8s321,和d20s82)为MSI EMAST和贝塞斯达面板。对hMSH3、c-erbB2的免疫组织化学检测EGFR和胸苷酸合成酶进行。临床特点和预后的相关性进行了评估。 结果:我们确定了22个EMAST阳性肿瘤(22%)及32微星高(MSI-H)肿瘤(32%)。EMAST更频繁比结肠癌直肠癌(P = 0.033),和具有MSI-H表型相关(P<0.001),低表达的hMSH3(P = 0.004),与胸苷酸合成酶的表达(P = 0.006)。38 MSI-L肿瘤中只有一个(4.5%)显示EMAST。长期的肿瘤学结果从总体和无病生存率EMAST和非EMAST肿瘤之间的相似。 结论:EMAST更密切的关系比MSI-L和MSS状态稳定。EMAST的临床和分子特征在肿瘤位置不同,胸苷酸合成酶的表达,表达的MSI和hMSH3。我们的初步研究结果支持EMAST本作为一种新的潜在的分类器在CRC。
关键词: 大肠癌,EMAST、hMSH3、微卫星不稳定性,胸苷酸合成酶。
Current Molecular Medicine
Title:Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features
Volume: 16 Issue: 9
Author(s): H.S. Lee, K.U. Park, D.-W. Kim, M.H. lhn, W.H. Kim, A.N. Seo, H.E. Chang, S.K. Nam, S.Y. Lee, H.-K. Oh, S.-B. Kang
Affiliation:
关键词: 大肠癌,EMAST、hMSH3、微卫星不稳定性,胸苷酸合成酶。
摘要: Purpose: Recently, a different type of microsatellite instability (MSI) instability designated ‘elevated microsatellite alterations at selected tetranucleotide repeats’ (EMAST) has been reported in several neoplasms, but its clinical implications remain unclear. We aimed to determine the relationships among EMAST, MSI and clinicopathologic characteristics, including oncologic outcomes, in colorectal cancer (CRC).
Materials and Methods: We evaluated 100 sporadic CRC cases subjected to surgery using five markers (MYCL1, D9S242, D20S85, D8S321, and D20S82) for EMAST and the Bethesda panel for MSI status. Immunohistochemical detection of hMSH3, c-erbB2, EGFR and thymidylate synthase was performed. Clinical characteristics and prognostic relevance were assessed. Results: We identified 22 EMAST-positive tumors (22.0%) and 32 MSI-high (MSI-H) tumors (32.0%). EMAST was more frequent in colon cancer than rectal cancer (p=0.033), and associated with MSI-H phenotype (p<0.001), low expression of hMSH3 (p=0.004), and overexpression of thymidylate synthase (p=0.006). Among the 38 MSI-L tumors, only one (4.5%) showed EMAST. Long-term oncologic results in terms of overall and disease-free survival were similar between EMAST and non-EMAST tumors. Conclusion: EMAST is more closely related to MSI-H than MSI-L or MSS status. The clinical and molecular characteristics of EMAST were distinct in terms of tumor location, thymidylate synthase expression, MSI status and hMSH3 expression. Our preliminary findings support the utility of EMAST as a new potential classifier in CRC.Export Options
About this article
Cite this article as:
H.S. Lee, K.U. Park, D.-W. Kim, M.H. lhn, W.H. Kim, A.N. Seo, H.E. Chang, S.K. Nam, S.Y. Lee, H.-K. Oh, S.-B. Kang , Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features, Current Molecular Medicine 2016; 16 (9) . https://dx.doi.org/10.2174/1566524016666161124103020
DOI https://dx.doi.org/10.2174/1566524016666161124103020 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dichotomous Life of DNA Binding High Mobility Group Box1 Protein in Human Health and Disease
Current Protein & Peptide Science Superheated Water as Solvent in Microwave Assisted Organic Synthesis of Compounds of Valuable Pharmaceutical Interest
Current Organic Chemistry The Potential Role of Pharmacogenomic and Genomic in the Adjuvant Treatment of Early Stage Non Small Cell Lung Cancer
Current Genomics Perspectives of Protein Kinase C (PKC) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry Editorial (Thematic Issue: Signalling Pathways in Anti-cancer Drug Resistance)
Current Medicinal Chemistry The Signal Pathway of Antibiotic Alternatives on Intestinal Microbiota and Immune Function
Current Protein & Peptide Science Recent Advances in the Synthesis and Development of Curcumin, its Combinations and Formulations and Curcumin-like Compounds as Anti-infective Agents
Current Medicinal Chemistry Gastrointestinal Non Colorectal Cancer. Do Elderly Patients Need a Specific Management?
Anti-Cancer Agents in Medicinal Chemistry Episensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment
Anti-Cancer Agents in Medicinal Chemistry Targeted Therapies in Gynecologic Cancers
Current Cancer Drug Targets Mechanisms for Targeted Delivery of Nanoparticles in Cancer
Current Pharmaceutical Design Progress in Nutritional and Health Profile of Milk and Dairy Products: A Novel Drug Target
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of COX-2 in Oral Cancer Development, and Chemoprevention/ Treatment of Oral Cancer by Selective COX-2 Inhibitors
Current Pharmaceutical Design Glioma: Tryptophan Catabolite and Melatoninergic Pathways Link microRNA, 14-3- 3, Chromosome 4q35, Epigenetic Processes and other Glioma Biochemical Changes
Current Pharmaceutical Design Targeting the Tumor Stroma in Cancer Therapy
Current Pharmaceutical Biotechnology Influence of Prebiotics on the Human Immune System (GALT)
Recent Patents on Inflammation & Allergy Drug Discovery Mutations of Chromatin Structure Regulating Genes in Human Malignancies
Current Protein & Peptide Science Macrocyclic Histone Deacetylase Inhibitors
Current Topics in Medicinal Chemistry Antiangiogenic Resistance: Novel Angiogenesis Axes Uncovered by Antiangiogenic Therapies Research
Current Drug Targets Epidermal Growth Factor Receptor-Targeted Therapy of Colorectal Cancer with Panitumumab
Current Cancer Therapy Reviews